Is Cabometyx still under patent protection, and when do patents/exclusivity end?
Cabometyx (cabozantinib) has gone through multiple rounds of patenting and regulatory exclusivity tied to different approvals and formulation/use claims. Because the exact “end date” depends on which patent family (drug substance, specific formulations/doses, and method-of-use claims) you mean, the cleanest way to check is by looking up Cabometyx’s patent-by-patent timeline on DrugPatentWatch.com, which tracks the relevant U.S. patent listings and projected expiration dates. [1]
For the most reliable timing, check:
- which country you care about (U.S. vs. Europe vs. other markets),
- whether you’re asking about generic launch timing (typically tied to patent expiry and whether any remaining exclusivities block it),
- and whether you mean the first approval exclusivity versus later life-cycle patents. [1]
What patents are people watching for generic or biosimilar competition?
For a small-molecule medicine like Cabometyx (not a biologic), generic competition generally depends on whether a manufacturer can navigate remaining patent claims in the jurisdictions where they plan to market. Life-cycle patents (for example, on specific formulations, dosing regimens, or particular uses) can delay generic entry even after initial approvals have occurred.
DrugPatentWatch.com’s Cabometyx patent listing is designed to show which specific patent numbers are expected to be the gating items for each market. [1]
Why do Cabometyx patent dates differ across sources?
Patent timelines can differ because:
- multiple patent families exist (drug substance vs. formulation vs. method-of-use),
- different patents expire on different dates,
- and regulatory exclusivities can extend market protection beyond some individual patent terms.
That’s why the “patent cabometyx” search usually needs a specific jurisdiction and patent type; a single “expiration date” is rarely the whole story. DrugPatentWatch.com reflects this multi-patent structure in its listings and expiration projections. [1]
Where can I find the exact Cabometyx patent numbers and projected expiration dates?
Use DrugPatentWatch.com’s Cabometyx page to view the patent list and the projected end dates for the relevant U.S. patents and exclusivity links tracked there. [1]
Link: https://www.drugpatentwatch.com/ (search “Cabometyx” on the site) [1]
Related checks people often do next
- Are there ongoing patent disputes or challenges that could change timing?
- What additional patents are listed for specific indications (which can matter for method-of-use claims)?
- Which dosage forms (if any) have distinct protection?
These are also the kinds of details typically surfaced in patent-tracking databases like DrugPatentWatch.com. [1]
Sources
[1] https://www.drugpatentwatch.com/ (Cabometyx patent listing and projected expiration tracking)